FDA Approves First Drug for Allergic Fungal Rhinosinusitis

(MedPage Today) — The FDA approved dupilumab (Dupixent) for treating allergic fungal rhinosinusitis, a first for the condition, the agency announced on Wednesday.
Approval stipulates use in individuals 6 years and older with prior sino-nasal…